lobbying_activities: 3089481

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts. Sortable columns (indexed): client_name, issue_code, filing_year, filing_uuid. Sorting on any other column returns HTTP 400 (2026-09-04, #697) — use ?sql= with your own ORDER BY if you need it.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	is_no_activity	is_termination	received_date
3089481	0680cfdd-acd5-4b89-a5c0-0b3679cc3ebc	Q4	RED+BLUE STRATEGIES	400693064	QUEST DIAGNOSTICS INCORPORATED	2023	fourth_quarter	MMM	H.R. 6363 - Further Continuing Appropriations and Other Extenders Act of 2024 - Issues related to maintaining support for laboratory programs and services for the upcoming fiscal year. Issues related to specific, federally-reimbursed drug testing protocols. H.R. 1835- The Saving Access to Laboratory Services Act - Issues related to the treatment of clinical labs in the Medicare program. Rules, regulations and guidance related to the end of the public health emergency and the treatment of Covid testing, pathology and other related issues.	HOUSE OF REPRESENTATIVES,SENATE	0	0	2023-12-31T14:37:18-05:00